Zusammenfassung
Die Verwendung autologer Transplantate gilt als Goldstandard in der Therapie kongenitaler oder erworbener Defekte. Die Gewinnung autologer Transplantate ist jedoch oft limitiert. Die regenerative Medizin zielt auf die intrinsischen, autologen regenerativen Mechanismen des Individuums und vereint die Kentnisse des Tissue-Engineerings, der Zell- bzw. Systembiologie, der Gentherapie und der Stammzellbiologie. Die meisten Ansätze des Tissue-Engineerings basieren auf der Expansion kleiner autologer Zellverbände des Patienten. Tissue-Engineering mit Hilfe von isolierten und amplifizierten Stammzellen stellt eine weitere vielversprechende Möglichkeit zur Herstellung autologer Transplantate dar und so die limitierte Verfügbarkeit zu überwinden. Die Kombination stammzellbasierten Tissue-Engineerings mit der Gentherapie erlaubt es, regeneratives Gewebe im optimalen Umfeld von Regulatorproteinen zu schaffen. Hieraus ergeben sich große Chancen für die Transplantation von Haut, Knochen oder Knorpel. In diesem Beitrag sollen der aktuelle Stand, der mögliche Nutzen, aber auch die Grenzen der regenerativen Medizin für die rekonstruktive Kopf-Hals-Chirurgie herausgestellt werden.
Abstract
Autologous transplantation is regarded as the gold standard in the treatment of congenital or acquired deformities. However, the availability of autologous tissue for transplantation is often limited. Regenerative medicine aims to activate individuals’ own intrinsic regenerative mechanisms and embraces tissue engineering, cell/system biology, gene therapy and stem-cell biology. Most approaches in tissue engineering are based on the expansion of small autologous cell aggregates. Tissue engineering supplemented by isolated and amplified stem cells is another very promising option for producing autologous transplants and getting over the limited availability. The association of stem cell-based tissue engineering and gene therapy allows the creation of regenerative tissue in the optimal ambience of regulatory proteins. This leads to great opportunities in the transplantation of skin, bones or cartilage. This paper presents the current status and the possible benefits, but also the limitations, of regenerative medicine in reconstructive surgery of the head and neck.
Literatur
Aigner J, Eblenkamp M, Wintermantel E (2005) Techniques for functional tissue and organ replacement using postnatal stem cells. Chirurg 76: 435–444
Allen RE, Temm-Grove CJ, Sheehan SM, Rice G (1997) Skeletal muscle satellite cell cultures. Methods Cell Biol 52: 155–176
Alsberg E, Hill EE, Mooney DJ (2001) Craniofacial tissue engineering. Crit Rev Oral Biol Med 12: 64–75
Arosarena O (2005) Tissue engineering. Curr Opin Otolaryngol Head Neck Surg 13: 233–241
Atala A (2004) Tissue engineering and regenerative medicine: concepts for clinical application. Rejuvenation Res 7: 15–31
Atala A (2006) Recent developments in tissue engineering and regenerative medicine. Curr Opin Pediatr 18: 167–171
Augustin HG (2003) Angiogenesis research – quo vadis? Ophthalmologe 100: 104–110
Bach AD, Beier JP, Stern-Staeter J, Horch RE (2004) Skeletal muscle tissue engineering. J Cell Mol Med 8: 413–422
Bader A (2002) Intersections of reconstructive surgery in the area of regenerative medicine. Chirurg 73: 428–434
Bannasch H, Föhn M, Unterberg T et al. (2003) Skin tissue engineering. Chirurg 74: 802–807
Bareille R, Lafage-Proust MH et al. (2000) Various evaluation techniques of newly formed bone in porous hydroxyapatite loaded with human bone marrow cells implanted in an extra-osseous site. Biomaterials 21: 1345–1352
Bartsch G Jr, Frimberger D (2004) Embryonic and adult stem cells for tissue engineering in urology. Urologe A 43: 1229–1236
Bello YM, Falabella AF, Eaglstein WH (2001) Tissue-engineered skin. Current status in wound healing. Am J Clin Dermatol 2: 305–313
Boo JS, Yamada Y, Okazaki Y et al. (2002) Tissue Engineered bone using mesenchymal stem cells and a biogradable scaffold. J Craniofac Surg 13: 231–239
Bostrom M, Lane JM, Tomin E et al. (1996) Use of bone morphogenetic protein-2 in the rabbit ulnar nonunion model. Clin Orthop 327: 272–282
Boyan BD, Lohmann CH, Romero J, Schwartz Z (1999) Bone and cartilage tissue engineering. Clin Plast Surg 26: 629–645
Braun-Falco M (2002) Gene therapy concepts for promoting wound healing. Hautarzt 53: 238–243
Bücheler M (2002) Tissue engineering in otorhinolaryngology, head and neck surgery. Laryngorhinootologie (Suppl 1) 81: S61–80
Bücheler M, Haisch A (2003) Tissue engineering in otorhinolaryngology. DNA Cell Biol 22: 549–564
Bundesministerium für Bildung und Forschung (BMBF); Regenerative Medizin und Biologie – Die Heilungskräfte unseres Körpers verstehen und nutzen, Bonn, Berlin 2005; http://www.bmbf.de/pub/regenerative_medizin_biologie.pdf
Cole J, Tsou R, Wallace K et al. (2001) Comparison of normal human skin gene expression using cDNA microarrays. Wound Repair Regen 9: 77–85
Crystal RG (1995) Transfer of genes to humans: early lessons and obstacles to success. Science 270: 404–410
Daculsi G, Passuti N, Martin S et al. (1990) Macroporous calcium phosphate ceramic for long bone surgery in humans and dogs. Clinical and histological study. J Biomed Mater Res 24: 379–383
Dazert S, Muller AM (2002) Stem cell biotechnology – revolution in established therapeutic methods? Laryngorhinootologie (Suppl 1) 81: S24–38
De Bari C, Dell Accio F, Luyten FP (2004) Failure of in vitro-differentiated mesenchymal stem cells from the synovial membrane to form ectopic stable cartilage in vivo. Arthritis Rheum 50: 142–150
Dennis RG, Kosnik PE 2nd, Gilbert ME, Faulkner JA (2001) Excitability and contractility of skeletal muscle engineered from primary cultures and cell lines. Am J Physiol Cell Physiol 280: C288–295
Deutsche Forschungsgemeinschaft (2007) Entwicklung der Gentherapie/Development of Gene Therapy; Stellungnahme der Senatskommission für Grundsatzfragen der Genforschung, Mitteilung 5/Report 5. Wiley-VCH, Weinheim
Dill-Müller D, Tilgen W (2005) Bewährte und aktuelle Verfahren in der Wundheilung. Hautarzt 56: 411–422
Eming SA, Krieg T, Davidson JM (2004) Gene transfer in tissue repair: status, challenges and future directions. Expert Opin Biol Ther 4: 1373–1386
Eming SA, Smola H, Krieg T (2002) Treatment of chronic wounds: state of the art and future concepts. Cells Tissues Organs 172: 105–117
Eming SA, Whitsitt JS, He L et al. (1999) Particle-mediated gene transfer of PDGF isoforms promotes wound repair. J Invest Dermatol 112: 297–302
Eriksson E, Yao F, Svensjo T et al. (1998) In vivo gene transfer to skin and wound by microseeding. J Surg Res 78: 85–91
Ferrera D, Poggi S, Biassoni C et al. (2002) Three-dimensional cultures of normal human osteoblasts: proliferation and differentiation potential in vitro and upon ectopic implantation in nude mice. Bone 30: 718–725
Gang EJ, Jeong JA, Hong SH et al. (2004) Skeletal myogenic differentiation of mesenchymal stem cells isolated from human umbilical cord blood. Stem Cells 22: 617–624
Gillitzer R (2002) Modernes Wundmanagement. Hautarzt 53: 130–147
Gillitzer R, Goebeler M (2001) Chemokines in cutaneous wound healing. J Leukoc Biol 69: 513–521
Giunta RE, Holzbach T, Taskov C et al. (2005) AdVEGF165 gene transfer increases survival in overdimensioned skin flaps. J Gene Med 7: 297–306
Goessler UR, Bugert P, Bieback K et al. (2006) A comparison of the gene expression patterns of human chondrocytes and chondrogen differentiated mesenchymal stem cells for tissue engineering. HNO 54: 258–266
Goessler UR, Bugert P, Bieback K et al. (2004) Expression of collagen and fiber-associated proteins in human septal cartilage during in vitro dedifferentiation. Int J Mol Med 14: 1015–1022
Goessler UR, Hörmann K, Riedel F (2004) Tissue engineering with chondrocytes and function of the extracellular matrix. Int J Mol Med 13: 505–513
Goessler UR, Hörmann K, Riedel F (2005) Adult stem cells in plastic reconstructive surgery. Int J Mol Med 15: 899–905
Goessler UR, Riedel K, Hormann K, Riedel F (2006) Perspectives of gene therapy in stem cell tissue engineering. Cells Tissues Organs 183: 169–179
Gojo S, Yamamoto S, Patience C et al. (2002) Gene therapy – its potential in surgery. Ann R Coll Surg Engl 84: 297–301
Grob D (1986) Probleme an der Entnahmestelle bei autogener Knochentransplantation. Unfallchirurg 89: 339–345
Guntinas-Lichius O (2002) Growth factors in otorhinolaryngology. Laryngorhinootologie (Suppl 1) 81: S39–60
Hadlock TA, Vacanti JP, Cheney ML (1998) Tissue engineering in facial plastic and reconstructive surgery. Facial Plast Surg 14: 197–203
Haisch A, Kläring S, Gröger A et al. (2002) A tissue-engineering model for the manufacture of auricular-shaped cartilage implants. Eur Arch Otorhinolaryngol 259: 316–321
Haisch A, Schultz O, Perka C et al. (1996) Tissue engineering of human cartilage tissue for reconstructive surgery using biocompatible resorbable fibrin gel and polymer carriers. HNO 44: 624–629
Hallfeldt KJ, Stuetzle H, Puhlmann M et al. (1994) The osteoinductive properties of partially demineralised bone matrix. Theorg Surg 9: 212–213
Heldin C-H, Westermark B (1999) Mechanism of action and in vivo role of platelet-derived growth factor. Phys Rev 79: 1283–1316
Hentz VR, Chang J (2001) Tissue engineering for reconstruction of the thumb. N Engl J Med 344: 1547–1548
Hom DB (2000) A new era of discovery in facial plastic surgery. Arch Facial Plast Surg 2: 166–172
Hom DB, Thatcher G, Tibesar R (2002) Growth factor therapy to improve soft tissue healing. Facial Plast Surg 18: 41–52
Hunziker T (2004) Autologous cultured skin substitutes. Hautarzt 55: 1077–1084
Hurvitz KA, Kobayashi M, Evans GR (2006) Current options in head and neck reconstruction. Plast Reconstr Surg 118: 122e–133e
Ikada Y (2006) Challenges in tissue engineering. J R Soc Interface 3: 589–601
Isogai N, Landis W, Kim TH et al. (1999) Formation of phalanges and small joints by tissue engineering. J Bone Joint Surg 81: 306–316
Jiang Y, Jahagirdar BN, Reinhardt RL et al. (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418: 41–49
Kanemaru S (2006) Regenerative medicine in the fields of otolaryngology; head and neck regions. Nippon Jibiinkoka Gakkai Kaiho 109: 1–7
Koch RJ, Gorti GK (2002) Tissue engineering with chondrocytes. Facial Plast Surg 18: 59–68
Lalan S, Pomerantseva I, Vacanti JP (2001) Tissue engineering and its potential impact on surgery. World J Surg 25: 1458–1466
Lauer G, Sollberg S, Cole M et al. (2000) Expression and proteolysis of VEGF is increased in chronic wounds. J Invest Dermatol 115: 12–18
Lee YM, Seol YJ, Lim YT et al. (2001) Tissue engineered growth of bone by marrow cell transplantation using porous calcium metaphosphate matrices. J Biomed Mates Res 54: 216–223
Levenberg S, Rouwkema J, Macdonald M et al. (2005) Engineering vascularized skeletal muscle tissue. Nat Biotechnol 23: 879–884
Li Q, Ping P, Zhang D (2002) Vascular endothelial growth factor (VEGF) accelerates maturation of prefabricated flap. Zhonghua Zheng Xing Wai Ke Za Zhi 18: 69–71
Machens HG, Mailander P (2005) Regenerative medicine and plastic surgery. Chirurg 76: 474–480
Machens HG, Morgan JR, Sachse C et al. (2000) Gene therapy possibilities in plastic surgery. Chirurg 71: 152–158
Madry H, Kohn D, Cucchiarini M (2006) Gene therapy in orthopaedic surgery. Orthopäde 35: 1193–1204
Messina A, Bortolotto SK, Cassell OC et al. (2005) Generation of a vascularized organoid using skeletal muscle as the inductive source. FASEB J 19: 1570–1572
Messina LM, Podrazik RM, Whitehill TA et al. (1992) Adhesion and incorporation of lacZ-transduced endothelial cells into the intact capillary wall in the rat. Proc Natl Acad Sci USA 89: 12018–12022
Mustoe TA, Han H (1999) The effect of new technologies on plastic surgery. Arch Surg 134: 1178–1183
Naumann A, Dennis J, Staudenmaier R et al. (2002) Mesenchymal stem cells – a new pathway for tissue engineering in reconstructive surgery. Laryngorhinootologie 81: 521–527
Naumann A, Rotter N, Bujia J, Aigner J (1998) Tissue engineering of autologous cartilage transplants for rhinology. Am J Rhinol 12: 59–63
Nussenbaum B, Krebsbach PH (2006) The role of gene therapy for craniofacial and dental tissue engineering. Adv Drug Deliv Rev 58: 577–591
Nussenbaum B, Teknos TN, Chepeha DB (2004) Tissue engineering: the current status of this futuristic modality in head neck reconstruction. Curr Opin Otolaryngol Head Neck Surg 12: 311–315
Oberholzer A, Stahel P, Tschoke SK, Ertel W (2006) Role of gene therapy in trauma and orthopedic surgery. Unfallchirurg 109: 521–527
Peiseler B (2001) Ohrmuscheln und Gelenke aus Zellkultur. Baseler Zeitung 16: 55–57
Philipp K, Riedel F, Sauerbier M et al. (2004) Targeting TGF-beta in human keratinocytes and its potential role in wound healing. International J Mol Med 14: 589–593
Pittenger MF, Mackay AM, Beck SC et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143–147
Polak J, Hench L (2005) Gene therapy progress and prospects: in tissue engineering. Gene Ther 12: 1725–1733
Puelacher WC, Mooney D, Langer R et al. (1994) Design of nasoseptal cartilage replacements synthesized from biodegradable polymers and chondrocytes. Biomaterials 15: 774–778
Puelacher WC, Wisser J, Vacanti CA et al. (1994) Temporomandibular joint disc replacement made by tissue engineered growth of cartilage. J Oral Maxillofac Surg 52: 1172–1177
Rettinger G (1992) Autogene und allogene Knorpeltransplantate in der Kopf- und Halschirurgie (ohne Mittelohr und Trachea). Eur Arch Otorhinolaryngol (Suppl) 1: 127–162
Riedel F, Hormann K (2001) Anti-angiogenesis – a therapy concept in the treatment of head and neck carcinomas? A review. Laryngorhinootologie 80: 535–541
Riedel F, Hormann K (2005) Plastic surgery of skin defects in the face – principles and perspectives. HNO 53: 1020–1036
Riedel F, Reinhart Goessler U, Grupp S et al. (2006) Management of radiation-induced tracheocutaneous tissue defects by transplantation of an ear cartilage graft and deltopectoral flap. Auris Nasus Larynx 33: 79–84
Riedel K, Riedel F, Goessler U et al. (2006) Current status of genetic modulation of growth factors in wound healing. Int J Mol Med 17: 183–193
Roth D, Kalish E, Castillo JR et al. (1999) Gene therapy with vascular endothelial growth factor improves survival in the rat tram flap. In: Proceedings of the 44th Annual Meeting of the Plastic Surgery Council, Pittsburgh/PA, May 22–25, 1999
Rotter N, Aigner J, Naumann A et al. (1999) Behavior of tissue-engineered human cartilage after transplantation into nude mice. J Mater Sci Mater Med 10: 689–693
Rotter N, Haisch A, Bucheler M (2005) Cartilage and bone tissue engineering for reconstructive head and neck surgery. Eur Arch Otorhinolaryngol 262: 539–545
Rotter N, Sittinger M, Hammer C et al. (1997) Transplantation of in vitro cultured cartilage materials: characterization of matrix synthesis. Laryngorhinootologie 76: 241–247
Rueger JM (1998) Knochenersatzmittel. Orthopäde 27: 72–79
Salgado AJ, Coutinho OP, Reis RL (2004) Bone tissue engineering: state of the art and future trends. Macromol Biosci 4: 743–765
Sato K, Li Y, Foster W et al. (2003) Improvement of muscle healing through enhancement of muscle regeneration and prevention of fibrosis. Muscle Nerve 28: 365–372
Schaefer DJ, Klemt C, Zhang XH, Stark GB (2000) Tissue engineering with mesenchymal stem cells for cartilage and bone regeneration. Chirurg 71: 1001–1008
Schantz JT, Hutmacher DW, Chim H et al. (2002) Induction of ectopic bone formation by using human periosteal cells in combination with a novel scaffold technology. Cell Transplant 11: 125–138
Shastri VP (2006) Future of regenerative medicine: challenges and hurdles. Artif Organs 30: 828–834
Sikavitsas VI, van den Dolder J, Banccroft GN et al. (2003) Influence of in vitro culture period on the in vivo performance of cell/titanium bone tissue engineered constructs using rat cranial critical size defect model. J Biomed Mater Res 67A: 944–951
Singer AJ, Clark RA (1999) Cutaneous wound healing. N Engl J Med 341: 738–746
Sittinger M (1995) Tissue engineering: artificial tissue replacement containing vital components. Laryngorhinootologie 74: 695–699
Smola H, Eming SA, Hess S et al. (2001) Wundheilung und Wundheilungsstörungen. Dt Ärzteblatt 98: 2400–2406
Staudenmaier R, Miehle N, Kleinsasser N et al. (2004) Tissue-engineered cartilage in a prefabricated microvascularized flap. HNO 52: 510–517
Steed DL (1995) Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers: Diabetic Ulcer Study Group. J Vasc Surg 21: 71
Stern-Straeter J, Bach AD, Stangenberg L et al. (2005) Impact of electrical stimulation on three-dimensional myoblast cultures – a real-time RT-PCR study. J Cell Mol Med 9: 883–892
Stern-Straeter J, Riedel F, Bran G et al. (2007) Advances in skeletal muscle tissue engineering. In vivo (in press)
Tanczos E, Horch RE, Bannasch H et al. (1999) Keratinocyte transplantation and tissue engineering. New approaches in treatment of chronic wounds. Zentralbl Chir (Suppl 1) 124: 81–86
Taub PJ, Marmur JD, Zhang WX et al. (1998) Locally administered vascular endothelial growth factor cDNA increases survival of ischemic experimental skin flaps. Plast Reconstr Surg 102: 2033
Taub PJ, Silver L, Weinberg H (2000) Plastic surgical perspectives on vascular endothelial growth factor as gene therapy for angiogenesis. Plast Reconstr Surg 105: 1034–1042
Tepper OM, Mehrara BJ (2002) Gene therapy in plastic surgery. Plast Reconstr Surg 109: 716–734
Tintut Y, Alfonso Z, Saini T et al. (2003) Multilineage potential of cells from the artery wall. Circulation 108: 2505–2510
Toma JG, Akhavan M, Fernandes KJ et al. (2001) Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 3: 778–784
Tonnesen MG, Feng X, Clark RAF (2000) Angiogenesis in wound healing. J Invest Dermatol 5: 40–46
Tsou R, Cole JK, Nathens AB et al. (2000) Analysis of hypertrophic scar and normal scar gene expression with cDNA microarrays. J Burn Care Rehabil 21: 541–550
Tsuchida H, Hashimoto J, Crawford E et al. (2003) Engineered allogenic mesenchymal stem cells repair femoral segment defects in rats. J Orthop Res 21: 44–53
Vacanti CA, Cima LG, Ratkowski D (1992) Tissue engineering growth of new cartilage in the shape of a human ear using synthetic polymers seeded with chondrocytes. Mat Res Soc Symp Proc 252: 367–374
Vacanti CA, Paige KT, Kim WS et al. (1994) Experimental tracheal replacement using tissue engineered cartilage. J Pediatr Surg 29: 201–205
Vacanti CA, Vacanti JP (1994) Bone and cartilage reconstruction with tissue engineering approaches. Otolaryngol Clin North Am 27: 263–276
van den Dolder J, Vehof J, Spauwen PH, Jansen JA (2002) Bone formation by rat bone marrow cells cultured on titanium fiber mesh: effect of in vitro culture time. J Biomed Mater Res 62: 350–358
von Garrel T, Gotzen L (1998) Allogenic bone transplantation and bone banking. Unfallchirurg 101: 713–727
Waller W, Lee J, Zhang F, Lineaweaver WC (2004) Gene therapy in flap survival. Microsurgery 24: 168–173
Yao F, Eriksson E (2000) Gene therapy in wound repair and regeneration. Wound Repair Regen 8: 443–451
Zhang F, Oswald T, Lin S et al. (2003) Vascular endothelial growth factor (VEGF) expression and the effect of exogenous VEGF on survival of a random flap in the rat. Br J Plast Surg 56: 653–659
Zuk PA, Zhu M, Mizuno H et al. (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7: 211–228
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Riedel, F., Goessler, U., Stern-Straeter, J. et al. Regenerative Medizin. HNO 56, 262–274 (2008). https://doi.org/10.1007/s00106-007-1604-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00106-007-1604-y